March 5, 2013

Integra LifeSciences to Participate in Investor Conferences in March

PLAINSBORO, N.J., March 5, 2013 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it will present at the following conferences in the next few weeks:

  • At 1:00 PM ET on Tuesday, March 12, 2013, Ms. Angela Steinway, Head of Investor Relations of Integra, will present at the Barclays Global Healthcare Conference in Miami, Florida. The presentation will not be webcast. However, Integra will host one-on-one meetings with investors. 
  • At 2:10 PM CT / 3:10 PM ET on Tuesday, March 19, 2013, Mr. Brian Larkin, President, Global Spine, and Head of Strategic Development of Integra, will present at the Canaccord Genuity Musculoskeletal Conference in Chicago, IL. This presentation will not be webcast.

Integra LifeSciences, a world leader in medical devices, is dedicated to limiting uncertainty for surgeons, so they can concentrate on providing the best patient care. Integra offers innovative solutions in orthopedics, neurosurgery, spine, reconstructive and general surgery. For more information, please visit www.integralife.com

The Integra LifeSciences Holdings Corp. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=440

Statements made at the upcoming conference may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve risks and uncertainties that could cause actual results to differ from predicted results. Forward-looking factors that may be discussed include, but are not limited to, future financial performance, new product development, governmental approvals, market potential and resulting sales as well as potential therapeutic applications, and additional acquisitions. These risks and uncertainties include market conditions and other factors beyond the Company's control and the economic, competitive, governmental, technological and other factors identified under the heading "Risk Factors" included in item IA of Integra's Annual Report on Form 10-K for the year ended December 31, 2012 and information contained in subsequent filings with the Securities and Exchange Commission could affect actual results. These forward-looking statements are made only as the date thereof, and the Company undertakes no obligation to update or revise the forward-looking statements, whether as a result of new information, future events or otherwise.

CONTACT: Integra LifeSciences Holdings Corporation

         

         John B. Henneman, III

         Corporate Vice President,

         Finance and Administration

         and Chief Financial Officer

         (609) 275-0500

         

         Investor Relations:

         Angela Steinway

         (609) 936-2268

         angela.steinway@integralife.com


Close window | Back to top

Copyright 2014 Integra LifeSciences Holdings Corporation